Search Contract Opportunities

Antidote Treatment Nerve Agent Auto-Injector (ATNAA)   3

ID: SPE2DP-23-R-0002 • Type: Presolicitation • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: April 12, 2024, 7:41 a.m. EDT

Solicitation: SPE2DP-23-R-0002

Item: ANTIDOTE TREATMENT, NERVE AGENT, Automatic, Dual-Chamber, Pralidoxime Chloride Injection, 300 mg per mL, 2 mL, and Atropine Injection, 2.99 mg per mL, 0.7 mL

NSN: 6505-01-362-7427

Description:

The Defense Logistics Agency Troop Support has a requirement for the supply of Antidote Treatment Nerve Agent Auto-Injector (ATNAA). ATNAA shall be made in accordance with MPID Number 6 dated May 2, 2019.

The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1).

The Government does not intend to use Part 12 for this acquisition per FAR 10.002(d)(2).

The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a base year and four (4) one-year options. The quantities for the base year and each option year are a minimum of 225,000 each and a maximum of 1,000,000 each.

Inspection/Acceptance at Destination

FOB Destination

Delivery Destination: Susquehanna, PA

Production Lead Time is 164 days after issuance date of the delivery order (DD1155).

All responsible sources may submit a proposal and shall be considered by the Agency.

The successful contractor shall have FDA approval to sell ATNAA before award decision.

****************************************************************************

IMPORTANT NOTICES

Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024.

******************************************************************************

Posted: March 20, 2024, 7:52 a.m. EDT
Show All

Overview

Agency
DLA Troop Support - Medical [DoD - DLA]
Response Deadline
April 4, 2024, 11:59 p.m. EDT Past Due
Posted
March 20, 2024, 7:52 a.m. EDT (updated: April 12, 2024, 7:41 a.m. EDT)
Set Aside
None
NAICS
325414 - Biological Product (except Diagnostic) Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Philadelphia, PA 19111 United States
Source
Open
Current SBA Size Standard
1250 Employees
Pricing
Fixed Price
Est. Level of Competition
Low
Odds of Award
48%
Vehicle Type
Indefinite Delivery Contract
On 3/20/24 DLA Troop Support - Medical issued Presolicitation SPE2DP-23-R-0002 for Antidote Treatment Nerve Agent Auto-Injector (ATNAA) due 4/4/24. The opportunity was issued full & open with NAICS 325414 and PSC 6505.

NATO Stock Number

Details for NSN 6505013627427

NSN
6505013627427
Item Name
ANTIDOTE TREATMENT - NERVE AGENT
NIIN
013627427
Standard Unit Price (DLA)
$22.03
Most Recent DLA Purchases
Approved Suppliers
Primary Contact
Name
Jessica De La Hoz   Profile
Email
jessica.delahoz@dla.mil
Phone
(215) 737-7137

Documents

Posted documents for Presolicitation SPE2DP-23-R-0002

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Presolicitation SPE2DP-23-R-0002

IDV Awards

Indefinite delivery vehicles awarded through Presolicitation SPE2DP-23-R-0002

Potential Bidders and Partners

Awardees that have won contracts similar to Presolicitation SPE2DP-23-R-0002

Similar Active Opportunities

Open contract opportunities similar to Presolicitation SPE2DP-23-R-0002

Experts for Antidote Treatment Nerve Agent Auto-Injector (ATNAA)

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2DP
Source Organization Code
500045946
Last Updated
April 19, 2024
Last Updated By
jessica.delahoz@dla.mil
Archive Date
April 19, 2024